Infusion of a Non HLA-Matched Off-the-Shelf Ex Vivo Expanded Cord Blood Progenitor Cell Product Following Myeloablative Cord Blood Transplantation Is Safe, Decreases the Time to Hematopoietic Recovery, and Results in Excellent Overall Survival

Category Primary study
JournalBlood
Year 2014
This article has no abstract
Epistemonikos ID: 77cc381c1ff9ec2ea8f21b5b341ed4ff4b7ade3c
First added on: Feb 19, 2025